PCI High Potent Manufacturing
LB Bohle – 10.06.2025
Temax_Krautz

Current Edition

Current Edition

Subsection - CDMO

Examining how innovative technologies, integrated manufacturing approaches and AI are shaping manufacturing.

Continue reading

Subsection - Injectables

Exploring advances in injectable drug delivery and sterile manufacturing, designed to improve patient-centric delivery.

Continue reading

Subsection - Neurodegenerative Diseases

Exploring emerging approaches to neurodegenerative disease research and treatment.

Continue reading

Subsection - Nasal & Pulmonary

Highlighting how advances in nasal and pulmonary drug delivery, formulation, devices and analytics are enabling more complex therapies.

Continue reading

Advertisement

CPHI 2027
DDL 2026

Advertisement

Nipro August 26

Advertisement

Merxin March 2026

Advertisement

Aurisco 300×250

Advertisement

Lifecore Biomedical
News

AstraZeneca’s Tezspire receives approval for asthma treatment

Green light for new asthma pen which offers a self-administration option across the EU. AstraZeneca’s (AZ) Tezspire has received a positive opinion from the Europ...
Continue Reading →
News

Moderna becomes latest company to join the ABPI

The company becomes the latest member of the ABPI and galvanises the company’s UK connections. Moderna is the latest member of the UK’s leading pharmaceutical ind...
Continue Reading →
News

Sarepta and Catalent expand manufacturing deal ahead of DMD gene therapy approval

Sarepta Therapeutics announced that it has signed a commercial supply agreement with CDMO giant Catalent to manufacture SRP-9001, Sarepta’s most advanced g...
Continue Reading →
News

Artificial pancreas technology set to change lives

Emerging technology could help patients who are unable to manage their type 1 diabetes. Individuals who are typically unable to manage their type 1 diabetes will ...
Continue Reading →
News

AstraZeneca makes CinCor Pharma acquisition

The agreement involves access to global rights of blood pressure lowering therapy baxdrostat. AstraZeneca (AZ) has agreed to acquire CinCor Pharma (CinCor) – a co...
Continue Reading →
News

Transgene receives approval to begin oncolytic virus trial

The study will evaluate the intravenous administration of the company’s multi-armed immunotherapy. Transgene – a company that develops virus-based immunotherapies...
Continue Reading →
News

BioNTech forms cancer immunotherapies partnership with UK Government

The collaboration will focus on providing up to 10,000 patients with personalised mRNA by 2030. BioNTech has announced a partnership with the UK Government that a...
Continue Reading →
News

Tower expands pharmaceutical corridors with new Singapore site

Pharmaceutical thermal protection specialist Tower Cold Chain is opening new office space in Tampines, Singapore, to support the company’s growth in the Asia Pacific...
Continue Reading →
News

Novavax begins phase 2 trial for combo influenza-COVID jab

Novavax announced this week that it has initiated the phase 2 trial evaluating the safety and efficacy of the COVID-19-Influenza Combination (CIC) jab in adults...
Continue Reading →
News

TG Therapeutics grabs FDA approval for MS drug

TG Therapeutics announced the U.S. FDA has approved its monoclonal antibody for the treatment of relapsing forms of multiple sclerosis (RMS), providing pat...
Continue Reading →

Advertisement

MedPharm 16/07

Advertisement

Biopharma group march 2026

Advertisement

Silgan March 2026

Advertisement

Terumo 06/26

Advertisement

Scott Pharma – 25.03.2025

Advertisement

Bespak

Advertisement

Solstice

Advertisement

Bachem skyscraper
Tjoapack
Aptar – 08/01/2026